LeanLife Health Inc.
LLP.CN · CNQ
3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.18 | 0.04 | 0.04 | -0.04 |
| FCF Yield | -10.77% | -10.46% | -61.32% | -22.27% |
| EV / EBITDA | -3.26 | -0.99 | -1.23 | -4.38 |
| Quality | ||||
| ROIC | -759.12% | 200.19% | -913.32% | -645.08% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.33 | 0.10 | 0.74 | 0.79 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -322.34% | 84.34% | 10.83% | -164.67% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | -0.00 | 0.01 | 0.02 |
| Interest Coverage | -569.41 | -5,449.77 | -1,853.86 | -2,050.29 |
| Efficiency | ||||
| Inventory Turnover | 0.01 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -50,604.27 | -49,208.04 | -8,711.11 | -15,185.58 |